Buy these dividend-paying real estate stocks ahead of earnings, says UBS
UBS analyst Michael Goldsmith said senior housing and skilled nursing REITs should see positive results ahead of summer earnings, citing muted supply growth, demographic tailwinds, near-90% Q2 occupancy (NIC MAP), and accretive acquisitions. UBS has buy ratings and raised price targets for American Healthcare REIT (to $63), and Welltower (to $271), plus maintained targets for CareTrust REIT ($48) and Omega Healthcare Investors ($54).
How this was made
The 30-second read
Why it matters
The actionable element is UBS’s pre-earnings positioning: AHR and WELL receive explicit price target increases, while CTRE and OHI are supported via maintained targets and specific FFO expectations into their earnings dates.
Market read
This is a pre-earnings analyst note that can influence near-term positioning, but it is not a new company disclosure beyond the cited equity raise and UBS’s target/estimate updates.
What to watch
The note emphasizes supply/demand and cost of capital, but does not quantify sensitivity to interest-rate moves, tenant reimbursement changes, or deal-by-deal underwriting variance.
Background
UBS argues senior housing benefits from muted supply growth and demographic tailwinds, with acquisitions remaining accretive and occupancy near 90% in Q2 per NIC MAP.
Ticker impact
UBS raised AHR’s price target to $63 and cites a ~$700mm equity raise to fund a SHOP pipeline over $1bn ahead of Q2 results.
Near-term upside bias into earnings, with volatility risk if results or acquisition economics disappoint.
The article provides specific UBS target change, the size/purpose of the equity raise, and a dated earnings catalyst, but it is still an analyst note rather than a company print.
UBS increased WELL’s price target to $271 from $249, pointing to improved cost of capital and management commentary ahead of July 27 earnings.
Moderate positive drift possible into the earnings date, with downside if FFO or growth mix misses.
The note includes a concrete target change and earnings timing, but the underlying new information is UBS interpretation of prior updates.
UBS maintained CTRE price targets and highlights UK care-home expansion, with an estimated early-August earnings date and a 3.88% dividend yield.
Limited incremental impact versus existing expectations; modest support if earnings confirm the expansion thesis.
CTRE is included with a stated thesis and yields, but the newest actionable detail is weaker because targets were maintained and no fresh company datapoint is disclosed.
UBS kept OHI’s price target at $54 and expects full-year core FFO of $3.25 per share, ahead of July 30 earnings.
Neutral-to-slightly positive positioning into earnings if results align with the FFO estimate.
The article offers a forecast and catalyst date, but the information is primarily analyst modeling rather than a newly reported company event.
Market effects
Reinforces the senior housing/skilled nursing REIT bull case: muted supply growth, demographic demand, and accretive acquisitions supporting dividends and FFO.
Highlights CTRE’s UK care-home expansion as a growth driver, implying cross-region demand resilience.
Limited direct global linkage; primarily US-focused demographic and supply dynamics with a UK-specific growth angle.
Counterpoint
Analyst optimism may underweight risks from higher-than-expected development costs, occupancy pressure, or acquisition execution that could dilute FFO/dividend coverage.
Key entities
- companyAmerican Healthcare REIT
UBS raised its price target to $63 and cites a ~$700mm equity raise to fund a SHOP pipeline over $1bn.
- companyWelltower
UBS raised its price target to $271, citing improved cost of capital and updated growth/mix commentary.
- companyCareTrust REIT
UBS highlights UK care-home expansion and maintains its price target ahead of an early-August earnings estimate.
- companyOmega Healthcare Investors
UBS maintains its price target and provides a full-year core FFO estimate ahead of July 30 earnings.
